XML 38 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Note 12 - Equity Incentive Plan
12 Months Ended
Nov. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
(
12
)
Equity Incentive Plan
 
The compensation cost charged against income was
$247,645
and
$195,416
for the
2020
and
2019
fiscal years, respectively. The total income tax deductions for share-based compensation arrangements were
$176,435
and
$122,022
for the
2020
and
2019
fiscal years, respectively.
No
compensation cost was capitalized as part of inventory or fixed assets.
 
On
February 25, 2020,
the Board of Directors of the Company (the “Board”) authorized and approved the Art's-Way Manufacturing Co., Inc.
2020
Equity Incentive Plan (the
“2020
Plan”). The
2020
Plan was approved by the stockholders on
April 30, 2020.
The
2020
Plan replaces the Art's-Way Manufacturing Co., Inc.
2011
Equity Incentive Plan (the
“2011
Plan”) and adds an additional
500,000
shares to the number of shares reserved for issuance pursuant to equity awards.
No
further awards will be made under the
2011
Plan or other prior plans. Awards to directors and executive officers under the
2020
Plan are governed by the forms of agreement approved by the Board of Directors. Stock options or other awards granted prior to
February 25, 2020
are governed by the applicable prior plan and the forms of agreement adopted thereunder.
 
The
2020
Plan permits the plan administrator to award nonqualified stock options, incentive stock options, restricted stock awards, restricted stock units, performance awards, and stock appreciation rights to employees (including officers), directors, and consultants. The Board has approved a director compensation policy pursuant to which non-employee directors are automatically granted restricted stock awards of
1,000
shares of fully vested common stock annually or initially upon their election to the Board and another
1,000
shares of fully vested common stock on the last business day of each fiscal quarter. During the year ended
November 30, 2020,
restricted stock awards of
128,750
shares were issued to various employees, directors, and consultants, which vest over the next
three
years, and restricted stock awards of
25,000
shares were issued to directors as part of the director compensation policy, which vested immediately upon grant. In comparison, during fiscal
2019,
restricted stock awards of
56,750
shares were issued to various employees, directors, and consultants, which vest over
three
years from the date of issuance, restricted stock awards of
9,000
shares were issued to various employees, which vested immediately upon grant, and restricted stock awards of
31,687
were issued to directors as part of the director compensation policy. During the
2020
fiscal year,
74,685
shares of restricted stock became unrestricted,
4,833
shares of restricted stock were forfeited, and the Company bought
16,255
shares back as treasury stock from employees to pay payroll tax on vested shares. During
2019
fiscal year,
32,600
shares of restricted stock became unrestricted,
1,400
shares of restricted stock were forfeited, and the Company bought
9,556
shares back as treasury stock from employees to pay payroll tax on vested shares.
 
Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant vesting period. The Company estimates the fair value of each stock-based option award on the measurement date using the Black-Scholes option valuation model which incorporates assumptions as to stock price volatility, the expected life of the options, risk-free interest rate, and dividend yield. Expected volatility is based on historical volatility of the Company's stock and other factors. The Company uses historical option exercise and termination data to estimate the expected term the options are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected dividend yield is calculated using historical dividend amounts and the stock price at the option issuance date.
No
stock options were granted during the years ended
November 30, 2020
or
2019.
Stock compensation net of treasury shares repurchased for the year ended
November 30, 2020
was
$216,649
compared to
$176,093
for the same period in fiscal
2019.
 
The fair value of each option award is estimated on the date of grant using the Black Scholes option-pricing model. Expected volatility is based on historical volatility of the Company's stock and other factors. The Company uses historical option exercise and termination data to estimate the expected term the options are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected dividend yield is calculated using historical dividend amounts and the stock price at the option issuance date.
 
   
20
20
   
201
9
 
Expected Volatility
   
-
     
-
 
Expected Dividend Yield
   
-
     
-
 
Expected Term (in years)
   
-
     
-
 
Risk-Free Rate
   
-
     
-
 
 
The following is a summary of activity under the plans as of
November 30, 2020
and
2019,
and changes during the years then ended:
 
2020 Option Activity
 
Options
 
Shares
   
Weighted Average Exercise Price
   
Weighted
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic Value
 
Options O/S at beginning of period
   
59,000
    $
6.07
     
 
     
 
 
Granted
   
-
    $
-
     
 
     
 
 
Exercised
   
-
    $
-
     
 
     
-
 
Options Expired or Forfeited
   
(23,000
)   $
5.56
     
 
     
 
 
Options O/S at end of Period
   
36,000
    $
6.40
     
2.57
     
-
 
Options Exercisable At end of the Period
   
36,000
    $
6.40
     
2.57
     
-
 
 
2019 Option Activity
 
Options
 
Shares
   
Weighted Average Exercise Price
   
Weighted
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic Value
 
Options O/S at beginning of period
   
59,000
    $
6.07
     
 
     
 
 
Granted
   
-
    $
-
     
 
     
 
 
Exercised
   
-
    $
-
     
 
     
-
 
Options Expired or Forfeited
   
-
    $
-
     
 
     
 
 
Options O/S at end of period
   
59,000
    $
6.07
     
2.86
     
-
 
Options Exercisable at end of the period
   
59,000
    $
6.07
     
2.86
     
-
 
 
No
options were granted or vested during the
2020
or
2019
fiscal years. As of both
November 30, 2020
and
November 30, 2019,
there were
no
non-vested options. As of
November 30, 2020,
there was
no
unrecognized compensation cost related to non-vested share-based compensation arrangements under the plan related to stock options.
 
The Company received
no
cash from the exercise of options during the
2020
or
2019
fiscal years.